P. Koivunen, Sungwoo Lee, Christopher Duncan, G. López, G. Lu, S. Ramkissoon, J. Losman, Päivi Joensuu, U. Bergmann, S. Gross, J. Travins, S. Weiss, R. Looper, K. Ligon, R. Verhaak, Hai Yan, W. Kaelin (2012)
Transformation by the R Enantiomer of 2-Hydroxyglutarate Linked to EglN ActivationNature, 483
B. Falini, I. Nicoletti, M. Martelli, C. Mecucci (2007)
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.Blood, 109 3
Kelly Moran-Crusio, Linsey Reavie, A. Shih, O. Abdel-Wahab, Delphine Ndiaye-Lobry, C. Lobry, M. Figueroa, A. Vasanthakumar, Jay Patel, Xinyang Zhao, F. Perna, Suveg Pandey, J. Madzo, Chun-Xiao Song, Qing Dai, Chuan He, S. Ibrahim, M. Beran, J. Zavadil, S. Nimer, A. Melnick, L. Godley, I. Aifantis, R. Levine (2011)
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation.Cancer cell, 20 1
C. Forristal, I. Winkler, B. Nowlan, V. Barbier, G. Walkinshaw, J. Lévesque (2013)
Pharmacologic stabilization of HIF-1α increases hematopoietic stem cell quiescence in vivo and accelerates blood recovery after severe irradiation.Blood, 121 5
W. Liu, Meng Guo, Ya-Bei Xu, Dao Li, Zhao-nian Zhou, Yingli Wu, Zhu Chen, S. Kogan, Guoqiang Chen (2006)
Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia.Blood, 107 2
T. Kitamura, T. Tange, T. Terasawa, S. Chiba, T. Kuwaki, K. Miyagawa, Y. Piao, K. Miyazono, A. Urabe, F. Takaku (1989)
Establishment and characterization of a unique human cell line that proliferates dependently on GM‐CSF, IL‐3, or erythropoietinJournal of Cellular Physiology, 140
Janeta Popovici-Muller, J. Saunders, F. Salituro, J. Travins, Shunqi Yan, Fang Zhao, S. Gross, L. Dang, K. Yen, Hua Yang, K. Straley, Shengfang Jin, K. Kunii, V. Fantin, Shunan Zhang, Qiongqun Pan, Derek Shi, S. Biller, Shinsan Su (2012)
Discovery of the First Potent Inhibitors of Mutant IDH1 That Lower Tumor 2-HG in Vivo.ACS medicinal chemistry letters, 3 10
F. Salomon‐Nguyen, V. Della-Valle, M. Mauchauffé, M. Coniat, J. Ghysdael, R. Berger, O. Bernard (2000)
The t(1;12)(q21;p13) translocation of human acute myeloblastic leukemia results in a TEL-ARNT fusion.Proceedings of the National Academy of Sciences of the United States of America, 97 12
P. Ward, Jay Patel, David Wise, O. Abdel-Wahab, Bryson Bennett, H. Coller, J. Cross, V. Fantin, C. Hedvat, A. Perl, J. Rabinowitz, M. Carroll, Shinsan Su, K. Sharp, R. Levine, C. Thompson (2010)
The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate.Cancer cell, 17 3
Li-Ping Song, Jing Zhang, S. Wu, Yuji Huang, Qing-hua Zhao, Jian Cao, Yeming Wu, Li-shun Wang, Guoqiang Chen (2008)
Hypoxia-inducible factor-1α-induced differentiation of myeloid leukemic cells is its transcriptional activity independentOncogene, 27
R. Chowdhury, K. Yeoh, Ya-min Tian, Lars Hillringhaus, Eleanor Bagg, N. Rose, Ivanhoe Leung, X. Li, E. Woon, Ming Yang, M. McDonough, Oliver King, I. Clifton, R. Klose, T. Claridge, P. Ratcliffe, C. Schofield, A. Kawamura (2011)
The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylasesEMBO reports, 12
C. Weinberg, K. Brown, D. Hoel (1987)
Altitude, radiation, and mortality from cancer and heart disease.Radiation research, 112 2
J. Ashton, M. Balys, S. Neering, D. Hassane, G. Cowley, D. Root, P. Miller, B. Ebert, H. McMurray, H. Land, C. Jordan (2012)
Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells.Cell stem cell, 11 3
Peter Jensen, Børge Mortensen, R. Hodgkiss, Per Iversen, I. Christensen, N. Helledie, J. Larsen (2000)
Increased cellular hypoxia and reduced proliferation of both normal and leukaemic cells during progression of acute myeloid leukaemia in ratsCell Proliferation, 33
Changho Choi, S. Ganji, R. Deberardinis, K. Hatanpaa, D. Rakheja, Z. Kovács, Xiao-Li Yang, T. Mashimo, J. Raisanen, I. Marín-Valencia, J. Pascual, C. Madden, B. Mickey, C. Malloy, R. Bachoo, E. Maher (2011)
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated glioma patientsNature medicine, 18
W. Xu, Hui Yang, Ying Liu, Ying Yang, ping wang, Se-Hee Kim, Shinsuke Ito, Chen Yang, Pu Wang, Mengtao Xiao, Lixia Liu, Wenyuan Jiang, Jing Liu, Jinye Zhang, Bin Wang, S. Frye, Yi Zhang, Yanhui Xu, Q. Lei, K. Guan, Shimin Zhao, Y. Xiong (2011)
Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.Cancer cell, 19 1
O. Abdel-Wahab, Jay Patel, R. Levine (2011)
Clinical implications of novel mutations in epigenetic modifiers in AML.Hematology/oncology clinics of North America, 25 6
M. Figueroa, O. Abdel-Wahab, Chao Lu, P. Ward, Jay Patel, A. Shih, Yushan Li, N. Bhagwat, A. Vasanthakumar, H. Fernandez, M. Tallman, Zhuoxin Sun, K. Wolniak, J. Peeters, Wei Liu, S. Choe, V. Fantin, E. Paietta, B. Löwenberg, J. Licht, L. Godley, R. Delwel, P. Valk, C. Thompson, R. Levine, A. Melnick (2010)
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.Cancer cell, 18 6
K. Takubo, N. Goda, W. Yamada, Hirono Iriuchishima, Eiji Ikeda, Y. Kubota, H. Shima, R. Johnson, A. Hirao, M. Suematsu, T. Suda (2010)
Regulation of the HIF-1alpha level is essential for hematopoietic stem cells.Cell stem cell, 7 3
Zachary Reitman, Geng-lin Jin, Edward Karoly, I. Spasojević, Jian Yang, K. Kinzler, Yiping He, D. Bigner, B. Vogelstein, Hai Yan (2011)
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolomeProceedings of the National Academy of Sciences, 108
K. Weber, U. Bartsch, C. Stocking, B. Fehse (2008)
A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis.Molecular therapy : the journal of the American Society of Gene Therapy, 16 4
L. Dang, D. White, S. Gross, Bryson Bennett, M. Bittinger, E. Driggers, V. Fantin, H. Jang, Shengfang Jin, M. Keenan, K. Marks, R. Prins, P. Ward, K. Yen, L. Liau, J. Rabinowitz, L. Cantley, C. Thompson, M. Heiden, Shinsan Su (2010)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarateNature, 465
E. Mardis, L. Ding, D. Dooling, D. Larson, M. McLellan, Ken Chen, D. Koboldt, R. Fulton, K. Delehaunty, S. McGrath, L. Fulton, Devin Locke, V. Magrini, R. Abbott, T. Vickery, Jerry Reed, J. Robinson, T. Wylie, Scott Smith, Lynn Carmichael, James Eldred, C. Harris, Jason Walker, Joshua Peck, Feiyu Du, Adam Dukes, Gabriel Sanderson, Anthony Brummett, Eric Clark, Joshua McMichael, R. Meyer, Jonathan Schindler, C. Pohl, J. Wallis, Xiaoqi Shi, Ling Lin, Heather Schmidt, Yuzhu Tang, C. Haipek, Madeline Wiechert, Jolynda Ivy, Joelle Kalicki, Glendoria Elliott, R. Ries, J. Payton, P. Westervelt, M. Tomasson, M. Watson, J. Baty, S. Heath, W. Shannon, R. Nagarajan, D. Link, M. Walter, T. Graubert, J. Dipersio, R. Wilson, T. Ley (2009)
Recurring mutations found by sequencing an acute myeloid leukemia genome.The New England journal of medicine, 361 11
F. Delhommeau, S. Dupont, V. Valle, C. James, Severine Trannoy, A. Massé, O. Kosmider, J. Couédic, F. Robert, A. Alberdi, Y. Lécluse, I. Plo, F. Dreyfus, C. Marzac, N. Casadevall, C. Lacombe, S. Romana, P. Dessen, J. Soulier, F. Viguié, M. Fontenay, W. Vainchenker, O. Bernard (2009)
Mutation in TET2 in myeloid cancers.The New England journal of medicine, 360 22
S. Gross, R. Cairns, M. Minden, E. Driggers, M. Bittinger, H. Jang, M. Sasaki, Shengfang Jin, D. Schenkein, Shinsan Su, L. Dang, V. Fantin, T. Mak (2010)
Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutationsThe Journal of Experimental Medicine, 207
G. Wang, K. Calvo, M. Pasillas, D. Sykes, H. Häcker, M. Kamps (2006)
Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8Nature Methods, 3
Dominic Chow, L. Wenning, W. Miller, E. Papoutsakis (2001)
Modeling pO(2) distributions in the bone marrow hematopoietic compartment. I. Krogh's model.Biophysical journal, 81 2
B. Luo, H. Cheung, A. Subramanian, Tanaz Sharifnia, M. Okamoto, Xiaoping Yang, G. Hinkle, J. Boehm, R. Beroukhim, B. Weir, C. Mermel, D. Barbie, Tarif Awad, Xiaochuan Zhou, T. Nguyen, Bruno Piqani, Cheng Li, T. Golub, M. Meyerson, N. Hacohen, W. Hahn, E. Lander, D. Sabatini, D. Root (2008)
Highly parallel identification of essential genes in cancer cellsProceedings of the National Academy of Sciences, 105
N. Eckhoff, J. Shultis, R. Clack, E. Ramer (1974)
Correlation of leukemia mortality rates with altitude in the United States.Health physics, 27 4
M. Sasaki, C. Knobbe, Joshua Munger, E. Lind, D. Brenner, A. Brüstle, I. Harris, Roxanne Holmes, A. Wakeham, J. Haight, A. You-Ten, Wanda Li, S. Schalm, Shinsan Su, C. Virtanen, G. Reifenberger, P. Ohashi, D. Barber, M. Figueroa, A. Melnick, J. Zúñiga-Pflücker, T. Mak (2012)
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigeneticsNature, 488
William Kaelin (2011)
Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases.Cold Spring Harbor symposia on quantitative biology, 76
Science – Unpaywall
Published: Feb 8, 2013
Access the full text.
Sign up today, get DeepDyve free for 14 days.